Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tubulin
79%
IC50
50%
Neoplasm
44%
Colchicine
39%
Gemcitabine
33%
Cisplatin
33%
Antiproliferative Activity
33%
Drug Resistance
29%
Cytotoxicity
28%
DNA Topoisomerase (ATP Hydrolysing)
25%
Camptothecin
25%
Anticancer Drug
24%
Indole
23%
Pharmacokinetic
23%
Combretastatin A4
23%
Anticarcinogen
22%
Fluorouracil
22%
Pancreas Cancer
22%
Folinic Acid
22%
Aurora Kinase Inhibitor
22%
Structure Activity Relationship
22%
Methylated DNA Protein Cysteine Methyltransferase
22%
Antimitotic Agent
21%
Binding Site
21%
Microtubule Inhibitors
18%
Sulfonamide
17%
Oxaliplatin
16%
DNA Methyltransferase
16%
Multidrug Resistance Associated Protein
16%
Maximum Tolerated Dose
15%
Nitrosourea
15%
Nasopharynx Carcinoma
15%
Paclitaxel
15%
Transcription Factor Nrf2
15%
Solid Malignant Neoplasm
15%
Antitumor Activity
13%
DNA Topoisomerase
13%
Caspase 9
12%
Caspase 3
12%
Aurora Kinase
12%
Caspase
12%
Chemotherapy
11%
Cyclin B1
11%
Tumor Growth
10%
Messenger RNA
10%
Multidrug Resistance Protein 1
10%
Uterine Cervix Cancer
9%
Antioxidant
9%
Squamous Cell Carcinoma
9%
Vincristine
8%
Clinical Trial
8%
Glutathione
8%
Ataxia Telangiectasia
8%
Mouse Model
8%
Uterine Cervix Carcinoma
8%
Protein P53
8%
Nude Mouse
8%
Chemoradiation Therapy
8%
Progression Free Survival
7%
Overall Survival
7%
Toluidine Derivative
7%
Peripheral T Cell Lymphoma
7%
8 (6 Methoxy 3 Pyridinyl) 3 Methyl 1 [4 (1 Piperazinyl) 3 (Trifluoromethyl)phenyl] 1h imidazo[4,5 C]quinolin 2(3h) One
7%
Diterpene
7%
Mouth Squamous Cell Carcinoma
7%
Cancer Pain
7%
Isonicotinamide
7%
Ketamine
7%
Liver Cell Carcinoma
7%
Somatomedin Binding Protein 3
7%
Survivin
7%
Intrathecal
7%
Head and Neck Squamous Cell Carcinoma
7%
Short Hairpin RNA
7%
Ubiquitin Conjugating Enzyme E2
7%
Vinorelbine
7%
Triterpene
7%
Salvia Miltiorrhiza
7%
2 Cyclohexenone
7%
Cetuximab
7%
Morphine
7%
RNA Binding Protein
7%
CD8 Antigen
7%
Cathepsin
7%
Transactivator Protein
7%
Chromosome Translocation
7%
Cell Adhesion Proteins
7%
Stomach Carcinoma
7%
Beta Tubulin
7%
Coix
7%
Benzylamine
7%
Arsenous Acid
7%
Arsenite
7%
ELAV Like Protein 1
7%
Cytotoxicity
7%
Protein Binding
7%
PPAR Agonist
7%
Thalidomide
7%
Irinotecan Sucrosofate
7%
Keyphrases
IC50 Value
30%
Tubulin Polymerization Inhibitors
30%
Novel Class
26%
Cancer Cell Lines
23%
Colchicine Binding Site
23%
Cancer Cells
22%
Tubulin
20%
Microtubules
19%
Antitubulin Agents
18%
8-dione
15%
Antimitotic Activity
15%
Colchicine
15%
Antitumor Agents
15%
Antimitotic Agents
15%
Benzenesulfonamide
15%
Antitumoral Activity
15%
IC50
15%
Sulfonamides
15%
Antiproliferative Activity
13%
Cdc2
11%
Cdc25
11%
MPM-2
11%
MKN45
11%
Cytotoxicity
11%
Structure-activity Relationship
11%
Combretastatin A4 Phosphate (CA4P)
10%
Indoline
10%
Cell Cycle Arrest
9%
Multidrug Resistance Protein
8%
Calocedrus Macrolepis
7%
KB Cells
7%
Bark
7%
Camptothecin Resistance
7%
Amino
7%
Peripheral T-cell Lymphoma
7%
NVP-BGT226
7%
PET Imaging
7%
CD226
7%
Cancer Management
7%
Smooth muscle Phenotype
7%
β-tubulin Isotypes
7%
Substitution Effect
7%
Ethynylation
7%
Cyanation
7%
Cluster of Differentiation 44 (CD44)
7%
Benzophenone Derivatives
7%
Glioma Stem Cells
7%
Suzuki Arylation
7%
Sonogashira
7%
Von Braun
7%
Structure-activity Analysis
7%
Isonicotinamide
7%
Regret
7%
Human Tissue Kallikrein
7%
Indole Compounds
7%
H460
7%
Cancer Cell Growth
7%
Retinoic Acid Signaling
7%
Blastocystis
7%
Anticancer Agents
7%
Cellular Retinoic Acid Binding Protein 2
7%
Clinical Testing
7%
Anisidine
7%
Benzyl
7%
Laminin-2
7%
Acquired Hemophilia A
7%
Co-cultured Cells
7%
Biochemotherapy
7%
Preclinical Testing
7%
Netropsin
7%
DNA Minor Groove Binding Agent
7%
Quinoline-5,8-dione
7%
Salvia Miltiorrhiza Bunge
7%
Oleanane-type Triterpene
7%
Ludwigia Octovalvis
7%
Danshen
7%
Arginine Deprivation
7%
Multidrug Sensitive
7%
Redox-mediated
7%
Nitrosourea
7%
Compound 13
7%
2,2-diphenyl-1-picrylhydrazyl Radical
7%
Apoptotic Pathway
7%
Human Cell Lines
7%
Drug-resistant Cancer
7%
α-ketoamides
7%
Alternative Transcripts
7%
MAPKAPK2
7%
2-amino-3
7%
Fixed Tissue
7%
M Phase
7%
Abietane-type Diterpene
7%
Abeo-Abietane
7%
DNA Topoisomerase
7%
Taiwania Cryptomerioides
7%
Malignancy
7%
Cell Death
7%
Antimutagenicity
7%
Adlay Hull
7%
Coix Lacryma-jobi L
7%
Immunology and Microbiology
Cancer Cell
24%
Cytotoxicity
20%
Squamous Cell Carcinoma Cell
19%
Neck
15%
Drug Resistance
15%
Integrin
15%
Squamous Cell
14%
Microtubule
12%
Lymph Node
12%
Colchicine
11%
Cell Death
11%
Caspase
11%
DNA Repair
11%
Cell Cycle M Phase
10%
KB Cell Line
10%
Programmed Cell Death
9%
Cell Migration
8%
Acanthamoeba
8%
Overall Survival
8%
Cell Proliferation
8%
Cell Cycle Arrest
7%
Cell Cycle Checkpoint
7%
Acanthamoeba castellanii
7%
Protein Binding
7%
Progression Free Survival
7%
Cell Population
7%
DNA Damage
7%
Malignant Progression
7%
DNA Adduct
7%
CD8
7%
Lymphangiogenesis
7%
Aminopeptidase
7%
Revertant
7%
Pseudomonas aeruginosa
7%
Protein Family
7%
Akt Signaling
7%
Aplastic Anemia
7%
Allogeneic Bone Marrow Transplantation
7%
Laminin
7%
Antineoplastic Activity
7%
Human Papillomavirus Type 16
7%
B Cell
7%
Glioma Stem Cell
7%
Antiangiogenic Activity
7%
Somatomedin
7%
Splenocyte
7%
Phagocytosis
7%
Coinfection
7%
CD44v Antigen
7%
Target Cell
7%
T Cell
7%
Repair Enzyme
7%
Nude Mouse
7%
Binding Site
6%
Cyclin B1
6%
Xenograft
6%
Bcl-2
6%
Chinese hamster
5%
Growth Inhibition
5%
Wart Virus
5%
Microtubule Assembly
5%
IC50
5%